GSK Update - tomorrow ( Wednesday ), page-10

Basically, we haven't heard any news of previous PH1 trials and whether
or not any will progress to PH2 or not,but the addition of a PH1b trial
into a type of bowel cancer has been revealed..........
That leads to a couple of thoughts.......
1....IMP731 has shown GSK enough to diversify in other cancer disciplines.....
2....PH1 trials recently completed and still under consideration....
3.....A Question, do you waste time considering failure?(not for me).
do you put quality time into considering the way forward for
promising ph 1 trials in its transition to PH2...(tick)

All conjecture, take it as you will....